White House proposes 23% cut to NASA budget, slashing science funding and prioritizing moon missions

The White House proposes $18.8B for NASA in FY2027, a 23% cut (~$5.6B) from the $24.4B Congress appropriated for 2026. The plan sharply reduces science funding, seeks to terminate over 40 'low‑priority' missions and trims ISS funding amid a shift to commercial successors, while continuing to prioritize an Artemis lunar landing in 2028 and a moon base; Artemis II launched this week. Expect sector-level pressure on science programs and certain aerospace contractors, but final funding will be decided in congressional negotiations.

Analysis

The administration-level reprioritization creates an asymmetric flow of programmatic work: large system integrators that can re-package lunar/systems-of-systems work (avionics, propulsion, habitats) become natural consolidators of budget that survives political negotiation, while boutique instrument shops that live off incremental science missions face rapid revenue erosion and talent attrition. Expect margins to compress for vendors whose product cycles depended on steady NASA science cadence; conversely, primes can extract higher margins negotiating single-source follow-ons for lunar surface architecture because schedule risk raises switching costs.

A near-term funding cliff increases demand uncertainty for commercial LEO platforms: reduced agency buy will expose whether a private market is genuine or merely aspirational. If Congress restores full or partial funding (most likely within the 3–9 month appropriations window), the recovery will disproportionately favor primes with demonstrable lunar IP and on-budget delivery history — those are the winners on a “restoration” catalyst.

Tail risks include political escalation (election-driven vetoes or deeper program cuts) and a high-visibility Artemis failure, either of which could shift appropriations outcomes within weeks and send correlated sell-offs across suppliers. Monitor three high-leverage triggers: (1) Congressional appropriations language (committee markups over the next 2–6 months), (2) NASA program baseline updates (cost/schedule slips published 3–9 months), and (3) any Artemis operational anomaly — each will reprice winners and losers sharply.

Contrarian angle: the political playbook historically results in partial restoration rather than permanent termination; the market may be over-discounting equities tied to government systems integration. That implies transient cheapness in select midsized suppliers with lunar-related backlog — they look like tactical buys on meaningful dips if the appropriation process follows historical norms.

Key Decisions for Investors

• Buy LMT 12-month call spread (buy ATM, sell ~+15% OTM) sized 2–4% of portfolio notional. R/R: limited premium loss (~3–5% of notional) vs 12–18%+ upside if Congress restores funding or primes win incremental lunar awards within 6–12 months. Catalyst window: 3–9 months (appropriations + program awards).
• Pair trade: Long RTX (cash) / Short PL (Planet Labs) 3–9 month horizon, equal dollar legs. Thesis: RTX to capture reallocated systems work; PL to see near-term revenue hits from cancelled Earth-science buys. Target: RTX +15% / PL -20%; stop-loss 10% on either leg.
• Initiate a tactical long MAXR (Maxar) position (3–12 months) sized 1–2% of portfolio. Rationale: differentiated capability for lunar imaging/defense re-tasking if science missions cut. Risk: 12–18% downside if broader gov’t spend is pared; target 25–35% upside on contract reallocation.
• Establish a small opportunistic short of pure-play science instrument or small-satellite OEMs (select names like PL or peers) following any initial earnings/Guidance cut; horizon 3–6 months. Risk: political reversal could snap short losses; keep small size and tighten stops at funding-restoration signals (committee reports, earmarks).